Theorem Clinical Research Release: Christian Tucat, MBA Appointed Vice President & General Manager, Europe Middle East & Africa (EMEA)
“Christian’s primary objective is to grow Theorem’s business in these markets by helping to penetrate new business opportunities, building upon our existing customers, and by leveraging Theorem’s strengths here,” said John Potthoff, PhD, President and CEO of Theorem Clinical Research.
Mr. Tucat brings a wealth of clinical research Operational and Business Development success, as well as Pharmaceutical and entrepreneurial experience, to this role. Before his appointment, Mr. Tucat served as Theorem’s Vice President, Business Development—International. Prior to joining Theorem, he spent seven years at PRA, most recently as a Senior Vice President of Business Development EAPA, playing a fundamental part in PRA’s growth in the region. Prior to PRA, Mr. Tucat held several senior positions at Eli Lilly and GSK, both in the United Kingdom.
Mr. Tucat holds an MBA from the Rotterdam School of Management (Erasmus Graduate School) in the Netherlands and a Bachelor’s Degree in Business Administration from the Universidad Argentina de la Empresa in Buenos Aires, Argentina.
About Theorem Clinical Research (previously Omnicare Clinical Research)
Established in 1985, Theorem Clinical Research is a leading global, full-service contract research organization (CRO) headquartered in King of Prussia, Pennsylvania. With office locations in 32 countries, the mid-sized firm has relationships with customers all across the globe comprised of some of the world’s leading pharmaceutical, biotechnology and medical device companies. Theorem is specialized in medical device and technical services with pharmaceutical development (Phase I-IV) focused on proactive project management and fast to first-patient-in. For more information on Theorem, visit: www.TheoremClinical.com.